MUSCULAR Dystrophy UK has announced that it is investing £1.3 million into 11 new research projects across England, Scotland, Northern Ireland and Wales.
The leading charity for more than 110,000 children and adults in the UK living with one of over 60 muscle wasting and weakening conditions will be funding two PhD studentships, two three-year project grants, three 12-month grants and four two-year project grants that aim to improve diagnosis, monitor progression, and test potential new treatments.
The research projects cover a range of different conditions including Becker muscular dystrophy, Charcot-Marie-Tooth disease, Duchenne muscular dystrophy, mitochondrial myopathy, myasthenia gravis, myotonic dystrophy type 1 and for the first time ADSSL1 myopathy and X-linked spinal muscular atrophy (XL-SMA).
